Changes to This Summary (03/24/2015)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Added Figure 2 about the marginal and cause-specific cumulative incidence of cardiac events in childhood cancer survivors stratified according to different treatment groups (cited van der Pal et al. as reference 11).
Added Figure 3 about the risk of anthracycline-induced clinical heart failure according to cumulative anthracycline dose (cited van Dalen et al. as reference 9).
Added Figure 7 about the prevalence of endocrine disorders at the last follow-up visit, by gender (cited Brignardello et al. as reference 24).
This summary is written and maintained by the PDQ Pediatric Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.